Hao Cui
Impact in
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Immune cells in cancer 5
- Immunotherapy and Immune Responses 2
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
- Co-authors
- Yuyue Zhao (6 shared papers)Guang‐Tao Yu (6 shared papers)Lushan Xiao (16 shared papers)Guowang Cheng (2 shared papers)Li Liu (12 shared papers)Chang Hong (10 shared papers)Lang Rao (1 shared paper)Qian‐Fang Meng (1 shared paper)
In The Last Decade
Hao Cui
28 papers receiving 351 citations
Peers
Comparison fields: 5 of 69
- Immunology 72
- Hepatology 23
- Oncology 55
- Biomaterials 28
- Nephrology 13
Countries citing papers authored by Hao Cui
This map shows the geographic impact of Hao Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Cui more than expected).
Fields of papers citing papers by Hao Cui
This network shows the impact of papers produced by Hao Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Cui. The network helps show where Hao Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 101 | |
| 2 | 2022 | 25 | |
| 3 | 2022 | 22 | |
| 4 | 2024 | 21 | |
| 5 | 2022 | 19 | |
| 6 | 2024 | 14 | |
| 7 | 2023 | 13 | |
| 8 | 2025 | 12 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 12 | |
| 11 | 2024 | 11 | |
| 12 | 2023 | 10 | |
| 13 | 2021 | 10 | |
| 14 | 2022 | 9 | |
| 15 | 2022 | 8 | |
| 16 | Tea Consumption is Associated with an Increased Risk of Hyperuricemia in an Occupational Population in Guangdong, China | 2022 | 8 |
| 17 | 2022 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2022 | 5 |
About Hao Cui
Hao Cui is a scholar working on Immunology, Oncology, Molecular Biology, Epidemiology and Nephrology, having authored 28 papers that have together received 352 indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Gout, Hyperuricemia, Uric Acid (2 papers), RNA Interference and Gene Delivery (2 papers), CAR-T cell therapy research (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Immunology (72 citations), Hepatology (23 citations), Oncology (55 citations), Biomaterials (28 citations) and Nephrology (13 citations). Hao Cui has collaborated with scholars based in China, Germany and Singapore. Frequent co-authors include Yuyue Zhao, Guang‐Tao Yu, Lushan Xiao, Guowang Cheng, Li Liu, Chang Hong, Lang Rao, Qian‐Fang Meng, Yuanwei Pan and Limin Ma. Their work appears in journals such as Oral Diseases, Advanced Science, Cancer Immunology Immunotherapy, Frontiers in Pharmacology and Clinical Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.